Content Area

Results in Studies to Determine the Optimal Use of Tadalafil Tablets- Several studies were conducted with the objective of determining the optimal use of tadalafil tablets in the treatment of ED. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-mg, and 20-mg groups, respectively, reported successful erections as defined above. Two studies were conducted to assess the efficacy of tadalafil tablets at a given time point after dosing, specifically at 24 hours and at 36 hours after dosing. In the first of these studies, 348 patients with ED were randomized to placebo or tadalafil tablets 20 mg. At the 36-hour time point (more specifically, 33 hours to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the tadalafil tablets 20-mg group. In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, tadalafil tablets 10 mg, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 hours and 36 hours post-dosing). At the 36-hour time point, the mean, per-patient percentage of attempts resulting in successful intercourse were 33%, 56%, and 62% for placebo, tadalafil tablets 10-mg, and 20-mg groups, respectively.

• Physical features of yellow Cialis include smooth coating and visible markings.
• Patients should avoid alcohol and grapefruit products while taking yellow Cialis.
• The yellow color of Cialis pills signifies it's a PDE5 inhibitor.
• The yellow Cialis pill is designed for quick absorption in the bloodstream.
• Before use, check the packaging for authenticity of the yellow Cialis.
• Side effects like dizziness may occur after taking yellow Cialis.
• The yellow Cialis pill is known for its consistency in quality.
• Cialis's active ingredient, tadalafil, is responsible for its effects.
• Always follow dosing guidelines to prevent potential health risks.
• The yellow Cialis pill enhances sexual performance by improving blood flow.
• Education about yellow Cialis helps patients use it effectively.
• Medical consultation is essential when considering yellow Cialis treatment.

The efficacy and safety of tadalafil tablet for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. Tadalafil tablet, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).

Ingredient	Amount per Dose	Purpose	Notes
Tadalafil	20 mg	Active ingredient, vasodilator	Main component for ED
Microcrystalline Cellulose	-	Filler	Binds ingredients
Magnesium Stearate	-	Excipient	Improves pill stability
Titanium Dioxide	-	Coloring agent	Provides yellow color

a Twenty-four-week study conducted in the US. The efficacy and safety of tadalafil tablet for once daily use for the treatment of the signs and symptoms of BPH was evaluated in 3 randomized, multinational, double-blinded, placebo-controlled, parallel-design, efficacy and safety studies of 12 weeks duration. Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, once a day cialis and other cardiovascular disease were included.

Generic vs Brand

In each of these 2 trials, tadalafil tablet 5 mg for once daily use resulted in statistically significant improvement in the total IPSS compared to placebo. Mean total IPSS showed a decrease starting at the first scheduled observation (4 weeks) in Study K and remained decreased through 12 weeks. In Study J, the effect of tadalafil tablet 5 mg once daily on cialis sublingual maximum urinary flow rate (Qmax) was evaluated as a secondary efficacy endpoint. In Study K, the effect of tadalafil tablet 5 mg once daily on Qmax was evaluated as a safety endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups (tadalafil tablet 5 mg: 1.6 mL/sec, placebo: 1.1 mL/sec); however, these changes were not significantly different between groups.

Why Should I Pay More For the Same Results?

Efficacy Results in Patients with BPH initiating Tadalafil Tablets and Finasteride – Tadalafil tablet for once daily use initiated together with finasteride was shown to be effective in treating the signs and symptoms of BPH in men with an enlarged prostate (>30 cc) for up to 26 weeks. Patients with multiple co-morbid conditions such as erectile dysfunction, diabetes mellitus, hypertension, and other cardiovascular disease were included. Tadalafil tablets with finasteride demonstrated statistically significant improvement in the signs and symptoms of BPH compared to placebo with finasteride, as measured by the total IPSS at 12 weeks, the primary study endpoint (see Table 20). The incremental benefit of tadalafil tablets beyond 26 weeks is unknown. Table 20: Mean Total IPSS Changes in BPH Patients in a Tadalafil Tablet for Once Daily Use Study Together with Finasteride In the 404 patients who had both ED and BPH at baseline, changes in erectile function were assessed as key secondary endpoints using the EF domain of the IIEF questionnaire.

For Benign Prostatic Hyperplasia

A statistically significant improvement from baseline (tadalafil tablets /finasteride 13.7, placebo/finasteride 15.1) was observed at week 4 (tadalafil tablets/finasteride 3.7, placebo/finasteride -1.1; p<0.001), week 12 (tadalafil tablets/finasteride 4.7, placebo/finasteride 0.6; p<0.001), and week 26 (tadalafil tablets/finasteride 4.7, placebo/finasteride 0; p<0.001). The efficacy and safety of tadalafil tablet for once daily use for the treatment of ED, and the signs and symptoms of BPH, in patients with both conditions was evaluated in one placebo-controlled, multinational, double-blind, parallel-arm study which randomized 606 patients to receive either tadalafil tablet 2.5 mg, 5 mg, for once daily use or placebo. Table 22: Mean SEP Question 3 Changes in the Tadalafil Tablet 5 mg for Once Daily Use Study in Patients with ED and BPH Tadalafil tablet for once daily use resulted in improvement in the IPSS total score at the first scheduled observation (week 2) and throughout the 12 weeks of treatment (see Figure 8). 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How SuppliedTadalafil tablets USP 2.5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘336’ on one side and plain on other side.NDC Number Size62332-177-30 bottle of 30 Tablets with child-resistant closure62332-177-71 bottle of 500 Tablets62332-177-91 bottle of 1000 Tablets62332-177-15 30 Tablets (2 blisters of 15 tablets)Tadalafil tablets USP 5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘337’ on one side and plain on other side.NDC Number Size62332-178-30 bottle of 30 Tablets with child-resistant closure62332-178-71 bottle of 500 Tablets62332-178-91 bottle of 1000 Tablets62332-178-15 30 Tablets (2 blisters of 15 tablets)Tadalafil tablets USP 10 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘338’ on one side and plain on other side.NDC Number Size62332-179-30 bottle of 30 Tablets with child-resistant closure62332-179-71 bottle of 500 Tablets62332-179-91 bottle of 1000 TabletsTadalafil tablets USP 20 mg are yellow to light yellow, oval shaped, beveled edge, coated tablets debossed with ‘L339’ on one side and plain cialis pastile on other side.NDC Number Size62332-180-30 bottle of 30 Tablets with child-resistant closure62332-180-71 bottle of 500 Tablets62332-180-91 bottle of 1000 Tablets Tadalafil tablets USP 2.5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘336’ on one side and plain on other side. 62332-177-30 bottle of 30 Tablets with child-resistant closure Tadalafil tablets USP 5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘337’ on one side and plain on other side. The primary efficacy endpoint in the two studies that evaluated the effect of tadalafil tablets for the signs and symptoms of BPH was the International Prostate Symptom Score (IPSS), a four week recall questionnaire that was administered at the beginning and end of a placebo run-in period and subsequently at follow-up visits after randomization. Maximum urinary flow rate (Qmax), an objective measure of urine flow, was assessed as a secondary efficacy endpoint in Study J and as a safety endpoint in Study K. The results for BPH patients with moderate to severe symptoms and a mean age of 63.2 years (range 44 to 87) who received either tadalafil tablet 5 mg for once daily use or placebo (N=748) in Studies J and K are shown in Table 19 and Figures 5 and 6, respectively. In each of these 2 trials, tadalafil tablet 5 mg for once daily use resulted in statistically significant improvement in the total IPSS compared to placebo. Mean total IPSS showed a decrease starting at the first scheduled observation (4 weeks) in Study K and remained decreased through 12 weeks. In Study J, the effect of tadalafil tablet 5 mg once daily on cialis sublingual maximum urinary flow rate (Qmax) was evaluated as a secondary efficacy endpoint. In Study K, the effect of tadalafil tablet 5 mg once daily on Qmax was evaluated as a safety endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups (tadalafil tablet 5 mg: 1.6 mL/sec, placebo: 1.1 mL/sec); however, these changes were not significantly different between groups. Efficacy Results in Patients with BPH initiating Tadalafil Tablets and Finasteride – Tadalafil tablet for once daily use initiated together with finasteride was shown to be effective in treating the signs and symptoms of BPH in men with an enlarged prostate (>30 cc) for up to 26 weeks. Patients with multiple co-morbid conditions such as erectile dysfunction, diabetes mellitus, hypertension, and other cardiovascular disease were included.

• The yellow Cialis pill can be taken with or without food for convenience.
• Some yellow Cialis pills come in 10mg or 20mg doses for different needs.
• The yellow color indicates a specific formulation of tadalafil medication.
• Cialis's molecular structure is designed to relax penile blood vessels.
• The yellow Cialis pill can be part of a treatment plan for ED.
• Proper dosage of yellow Cialis ensures minimal side effects.
• The yellow Cialis pill is a popular choice worldwide for ED treatment.
• Combining yellow Cialis with certain medications can be dangerous.
• Levitra and Viagra are other ED medications often compared with Cialis.
• Using yellow Cialis in excess can lead to dangerous health complications.
• Yellow Cialis pills are sometimes used by men seeking longer-lasting solutions.
• Always buy yellow Cialis from reputable sources to avoid counterfeit products.

Tadalafil tablets with finasteride demonstrated statistically significant improvement in the signs and symptoms of BPH compared to placebo with finasteride, as measured by the total IPSS at 12 weeks, the primary study endpoint (see Table 20). The incremental benefit of tadalafil tablets beyond 26 weeks is unknown.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	40mg	10 Pills	37.79€ 35.99€	Buy
Cialis Generic	5mg	30 + 4 Pills	53.56€ 51.01€	Buy
Cialis Generic	40mg	180 + 10 Pills	277.29€ 264.09€	Buy
Cialis Generic	10mg	20 Pills	48.23€ 45.93€	Buy
Cialis Generic	60mg	60 + 4 Pills	145.06€ 138.15€	Buy
Cialis Generic	10mg	30 + 4 Pills	63.32€ 60.30€	Buy
Cialis Generic	10mg	60 + 6 Pills	105.81€ 100.77€	Buy
Cialis Black	80mg	60 + 4 Pills	150.98€ 143.79€	Buy
Cialis Original	20mg	4 Pills	41.99€ 39.99€	Buy
Cialis Generic	20mg	180 + 10 Pills	254.09€ 241.99€	Buy
Cialis Generic	60mg	20 Pills	65.61€ 62.49€	Buy
Cialis Generic	10mg	10 Pills	31.41€ 29.91€	Buy
Cialis Black	80mg	180 + 10 Pills	356.64€ 339.66€	Buy

Table 20: Mean Total IPSS Changes in BPH Patients in a Tadalafil Tablet for Once Daily Use Study Together with Finasteride In the 404 patients who had both ED and BPH at baseline, changes in erectile function were assessed as key secondary endpoints using the EF domain of the IIEF questionnaire.

2.4 Dose Adjustment for Use with Ritonavir

Before taking tadalafil,

A statistically significant improvement from baseline (tadalafil tablets /finasteride 13.7, placebo/finasteride 15.1) was observed at week 4 (tadalafil tablets/finasteride 3.7, placebo/finasteride -1.1; p<0.001), week 12 (tadalafil tablets/finasteride 4.7, placebo/finasteride 0.6; p<0.001), and week 26 (tadalafil tablets/finasteride 4.7, placebo/finasteride 0; p<0.001).

• The yellow Cialis pill is a popular choice due to its reliability and effectiveness.
• It is essential to get proper medical evaluation before starting yellow Cialis.
• The brand's distinctive yellow color supports easy identification and safety.
• Yellow Cialis should be stored away from moisture and heat.
• The pill’s design includes specific markings for safety during manufacturing.
• Duration of effectiveness makes yellow Cialis suitable for planned or spontaneous use.
• Avoid taking yellow Cialis with certain real or herbal supplements without consultation.
• The yellow Cialis pill helps improve self-confidence in men with ED.
• Always use yellow Cialis under the guidance of a healthcare professional.
• The pill’s pharmacokinetics allows for up to 36 hours of efficacy.
• Be aware of possible side effects such as nasal congestion and muscle aches.
• Proper use of yellow Cialis can significantly improve quality of life.

The efficacy and safety of tadalafil tablet for once daily use for the treatment of ED, and the signs and symptoms of BPH, in patients with both conditions was evaluated in one placebo-controlled, multinational, double-blind, parallel-arm study which randomized 606 patients to receive either tadalafil tablet 2.5 mg, 5 mg, for once daily use or placebo. Table 22: Mean SEP Question 3 Changes in the Tadalafil Tablet 5 mg for Once Daily Use Study in Patients with ED and BPH Tadalafil tablet for once daily use resulted in improvement in the IPSS total score at the first scheduled observation (week 2) and throughout the 12 weeks of treatment (see Figure 8). 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How SuppliedTadalafil tablets USP 2.5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘336’ on one side and plain on other side.NDC Number Size62332-177-30 bottle of 30 Tablets with child-resistant closure62332-177-71 bottle of 500 Tablets62332-177-91 bottle of 1000 Tablets62332-177-15 30 Tablets (2 blisters of 15 tablets)Tadalafil tablets USP 5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘337’ on one side and plain on other side.NDC Number Size62332-178-30 bottle of 30 Tablets with child-resistant closure62332-178-71 bottle of 500 Tablets62332-178-91 bottle of 1000 Tablets62332-178-15 30 Tablets (2 blisters of 15 tablets)Tadalafil tablets USP 10 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘338’ on one side and plain on other side.NDC Number Size62332-179-30 bottle of 30 Tablets with child-resistant closure62332-179-71 bottle of 500 Tablets62332-179-91 bottle of 1000 TabletsTadalafil tablets USP 20 mg are yellow to light yellow, oval shaped, beveled edge, coated tablets debossed with ‘L339’ on one side and plain cialis pastile on other side.NDC Number Size62332-180-30 bottle of 30 Tablets with child-resistant closure62332-180-71 bottle of 500 Tablets62332-180-91 bottle of 1000 Tablets Tadalafil tablets USP 2.5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘336’ on one side and plain on other side. 62332-177-30 bottle of 30 Tablets with child-resistant closure Tadalafil tablets USP 5 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘337’ on one side and plain on other side. 62332-178-30 bottle of 30 Tablets with child-resistant closure Tadalafil tablets USP 10 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘338’ on one side and plain on other side. 62332-179-30 bottle of 30 Tablets with child-resistant closure Tadalafil tablets USP 20 mg are yellow to light yellow, oval shaped, beveled edge, coated tablets debossed with ‘L339’ on one side and plain on other side.

2. There are ways to save on Cialis

62332-178-30 bottle of 30 Tablets with child-resistant closure Tadalafil tablets USP 10 mg are yellow to light yellow, round shaped, beveled edge, coated tablets debossed with ‘338’ on one side and plain on other side. 62332-179-30 bottle of 30 Tablets with child-resistant closure Tadalafil tablets USP 20 mg are yellow to light yellow, oval shaped, beveled edge, coated tablets debossed with ‘L339’ on one side and plain on other side. 62332-180-30 bottle of 30 Tablets with child-resistant closure 17 PATIENT COUNSELING INFORMATION “See FDA-approved patient labeling (Patient Information)”17.1 NitratesPhysicians should discuss with patients the contraindication of tadalafil tablets with regular and/or intermittent use of organic nitrates. Patients should be counseled that concomitant use of tadalafil tablets with nitrates could cause blood pressure to suddenly drop to an unsafe level, resulting in dizziness, syncope, or even heart attack or stroke.Physicians should discuss with patients the appropriate action in the event that they experience anginal chest pain requiring nitroglycerin following intake of tadalafil tablets. Therefore, patients who experience anginal chest pain after taking tadalafil tablets should seek immediate medical attention [see Contraindications (4.1) and Warnings and Precautions (5.1)].17.2 Guanylate Cyclase (GC) StimulatorsPhysicians should discuss with patients the contraindication of tadalafil tablets with any use of a GC stimulator, such as riociguat, for pulmonary arterial hypertension.

What are the most common side effects of tadalafil?

Patients should be counseled that the concomitant use of tadalafil tablets with GC stimulators may cause blood pressure to drop to an unsafe level.17.3 Cardiovascular ConsiderationsPhysicians should consider the potential cardiac risk of sexual activity in patients with preexisting cardiovascular disease. Physicians should advise patients who experience symptoms upon initiation of sexual activity to refrain from further sexual activity and seek immediate medical attention [see Warnings and Precautions (5.1)].17.4 Concomitant Use with Drugs Which Lower Blood PressurePhysicians should discuss with patients the potential for tadalafil tablets to augment the blood-pressure-lowering effect of alpha-blockers and antihypertensive medications [see Warnings and Precautions (5.6), Drug Interactions (7.1), and Clinical Pharmacology (12.2)].17.5 Potential for Drug Interactions When Taking Tadalafil Tablet for Once Daily UsePhysicians should discuss with patients the clinical implications of continuous exposure to tadalafil when prescribing tadalafil tablet for once daily use, especially the potential for interactions with medications (e.g., nitrates, alpha-blockers, antihypertensives and potent inhibitors of cytochrome P450 3A4) and with substantial consumption of alcohol [see Dosage and Administration (2.7), Warnings and Precautions (5.6), Drug Interactions (7.1, 7.2), Clinical Pharmacology (12.2), and Clinical Studies (14.2)].17.6 PriapismThere have been rare reports of prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) for this class of compounds.

Your questions answered

62332-180-30 bottle of 30 Tablets with child-resistant closure 17 PATIENT COUNSELING INFORMATION “See FDA-approved patient labeling (Patient Information)”17.1 NitratesPhysicians should discuss with patients the contraindication of tadalafil tablets with regular and/or intermittent use of organic nitrates. Patients should be counseled that concomitant use of tadalafil tablets with nitrates could cause blood pressure to suddenly drop to an unsafe level, resulting in dizziness, syncope, or even heart attack or stroke.Physicians should discuss with patients the appropriate action in the event that they experience anginal chest pain requiring nitroglycerin following intake of tadalafil tablets.

Adverse effects

Results in Studies to Determine the Optimal Use of Tadalafil Tablets- Several studies were conducted with the objective of determining the optimal use of tadalafil tablets in the treatment of ED. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-mg, and 20-mg groups, respectively, reported successful erections as defined above. Two studies were conducted to assess the efficacy of tadalafil tablets at a given time point after dosing, specifically at 24 hours and at 36 hours after dosing. In the first of these studies, 348 patients with ED were randomized to placebo or tadalafil tablets 20 mg. At the 36-hour time point (more specifically, 33 hours to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the tadalafil tablets 20-mg group.

Cialis FAQ

In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, tadalafil tablets 10 mg, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 hours and 36 hours post-dosing). At the 36-hour time point, the mean, per-patient percentage of attempts resulting in successful intercourse were 33%, 56%, and 62% for placebo, tadalafil tablets 10-mg, and 20-mg groups, respectively. The efficacy and safety of tadalafil tablet for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. Tadalafil tablet, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED). a Twenty-four-week study conducted in the US.

Who should not use tadalafil?

The efficacy and safety of tadalafil tablet for once daily use for the treatment of the signs and symptoms of BPH was evaluated in 3 randomized, multinational, double-blinded, placebo-controlled, parallel-design, efficacy and safety studies of 12 weeks duration. Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, once a day cialis and other cardiovascular disease were included. The primary efficacy endpoint in the two studies that evaluated the effect of tadalafil tablets for the signs and symptoms of BPH was the International Prostate Symptom Score (IPSS), a four week recall questionnaire that was administered at the beginning and end of a placebo run-in period and subsequently at follow-up visits after randomization. Maximum urinary flow rate (Qmax), an objective measure of urine flow, was assessed as a secondary efficacy endpoint in Study J and as a safety endpoint in Study K. The results for BPH patients with moderate to severe symptoms and a mean age of 63.2 years (range 44 to 87) who received either tadalafil tablet 5 mg for once daily use or placebo (N=748) in Studies J and K are shown in Table 19 and Figures 5 and 6, respectively. Therefore, patients who experience anginal chest pain after taking tadalafil tablets should seek immediate medical attention [see Contraindications (4.1) and Warnings and Precautions (5.1)].17.2 Guanylate Cyclase (GC) StimulatorsPhysicians should discuss with patients the contraindication of tadalafil tablets with any use of a GC stimulator, such as riociguat, for pulmonary arterial hypertension.

• The yellow Cialis pill is often marketed with medical claims about ED treatment.
• Online ordering of yellow Cialis should be done cautiously to avoid scams.
• Yellow Cialis is used by men seeking a reliable solution for ED.
• The pill's color helps distinguish it from other ED medications like Viagra.
• Dosage adjustments for yellow Cialis depend on individual health factors.
• The yellow Cialis pill can be taken on an empty stomach for quicker results.
• The safety profile of yellow Cialis has been established through clinical trials.
• Cialis, including the yellow dosage form, is prescribed worldwide.
• Regular monitoring by a healthcare provider enhances safe use of yellow Cialis.
• The yellow Cialis pill is an effective, long-lasting option for ED.
• Potential interactions with other medications should be managed under medical advice.
• The yellow Cialis pill is a widely trusted medication for ED management.

Patients should be counseled that the concomitant use of tadalafil tablets with GC stimulators may cause blood pressure to drop to an unsafe level.17.3 Cardiovascular ConsiderationsPhysicians should consider the potential cardiac risk of sexual activity in patients with preexisting cardiovascular disease. Physicians should advise patients who experience symptoms upon initiation of sexual activity to refrain from further sexual activity and seek immediate medical attention [see Warnings and Precautions (5.1)].17.4 Concomitant Use with Drugs Which Lower Blood PressurePhysicians should discuss with patients the potential for tadalafil tablets to augment the blood-pressure-lowering effect of alpha-blockers and antihypertensive medications [see Warnings and Precautions (5.6), Drug Interactions (7.1), and Clinical Pharmacology (12.2)].17.5 Potential for Drug Interactions When Taking Tadalafil Tablet for Once Daily UsePhysicians should discuss with patients the clinical implications of continuous exposure to tadalafil when prescribing tadalafil tablet for once daily use, especially the potential for interactions with medications (e.g., nitrates, alpha-blockers, antihypertensives and potent inhibitors of cytochrome P450 3A4) and with substantial consumption of alcohol [see Dosage and Administration (2.7), Warnings and Precautions (5.6), Drug Interactions (7.1, 7.2), Clinical Pharmacology (12.2), and Clinical Studies (14.2)].17.6 PriapismThere have been rare reports of prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) for this class of compounds.